Maravai Lifesciences Holdings (MRVI) Net Cash Flow Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Net Cash Flow Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | -88.82% |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn | 301.06% |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn | 453.08% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn | -125.22% |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 981.05 Mn | 815.13 Mn | 33.70 Mn | -36.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.29% |
| Dec 31, 2025 | 89.56% |
| Sep 30, 2025 | -627.98% |
| Jun 30, 2025 | -230.97% |
| Mar 31, 2025 | -181.96% |
| Dec 31, 2024 | -5,408.46% |
| Sep 30, 2024 | 973.20% |
| Jun 30, 2024 | 123.87% |
| Mar 31, 2024 | -243.36% |
| Dec 31, 2023 | -131.60% |
| Sep 30, 2023 | -100.86% |
| Jun 30, 2023 | -140.35% |
| Mar 31, 2023 | 96.77% |
| Dec 31, 2022 | 318.93% |
| Sep 30, 2022 | -61.38% |
| Jun 30, 2022 | -6.34% |
| Mar 31, 2022 | -1,143.22% |
| Dec 31, 2021 | -96.85% |
| Sep 30, 2021 | 328.05% |
| Jun 30, 2021 | 1,552.97% |